Lorenzo Cereser

Prof. Lorenzo Cereser

Department of Medicine (DMED), University of Udine, Udine, Friuli-Venezia Giulia, Italy
orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2010 in British Journal of Radiology
Verified
Journal Article
Closed access
RGRossano Girometti
Rossano Girometti
GBG Brondani
G Brondani
Lorenzo CereserLorenzo Cereser
Lorenzo Cereser
GCG Como
G Como
MPM Del Pin
M Del Pin
CZC Zuiani
C Zuiani
Post-cholecystectomy syndrome (PCS) is defined as a complex of heterogeneous symptoms, consisting of upper abdominal pain and dyspepsia, which recur and/or persist after cholecystectomy. Nevertheless, this term is inaccurate, as it encompasses biliary and non-biliary disorders, possibly unrelated to cholecystectomy. Biliary manifestations of PCS may occur early in the post-operative period, usually because of incomplete surgery (retained calculi in the cystic duct remnant or in the common bile duct) or operative complications, such as bile duct injury and/or bile leakage. A later onset is commonly caused by inflammatory scarring strictures involving the sphincter of Oddi or the common bile duct, recurrent calculi or biliary dyskinesia. The traditional imaging approach for PCS has involved ultrasound and/or CT followed by direct cholangiography, whereas manometry of the sphincter of Oddi and biliary scintigraphy have been reserved for cases of biliary dyskinesia. Because of its capability to provide non-invasive high-quality visualisation of the biliary tract, magnetic resonance cholangiopancreatography (MRCP) has been advocated as a reliable imaging tool for assessing patients with suspected PCS and for guiding management decisions. This paper illustrates the rationale for using MRCP, together with the main MRCP biliary findings and diagnostic pitfalls.

5 September 2018 in Journal of Magnetic Resonance Imaging
Verified
Journal Article
Closed access
PDF file
RGRossano Girometti
Rossano Girometti
GGGianluca Giannarini
Gianluca Giannarini
FGFranco Greco
Franco Greco
MIMiriam Isola
Miriam Isola
Lorenzo CereserLorenzo Cereser
Lorenzo Cereser
CZChiara Zuiani
Chiara Zuiani


17 August 2020 in The Ultrasound Journal
Verified
Journal Article
Open access
PDF file
Luigi VetrugnoLuigi Vetrugno
Luigi Vetrugno
MBMarco Baciarello
Marco Baciarello
EBElena Bignami
Elena Bignami
ABAndrea Bonetti
Andrea Bonetti
FSFrancesco Saturno
Francesco Saturno
TBTiziana Bove
Tiziana Bove
Coronavirus disease of 2019 (COVID-19) is a highly infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which has rapidly spread to a global pandemic in March 2020. This emergency condition has been putting a severe strain on healthcare systems worldwide, and a prompt, dynamic response is instrumental in its management. While a definite diagnosis is based on microbiological evidence, the relationship between lung ultrasound (LU) and high-resolution computed tomography (HRCT) in the diagnosis and management of COVID-19 is less clear. Lung ultrasound is a point-of-care imaging tool that proved to be useful in the identification and severity assessment of different pulmonary conditions, particularly in the setting of emergency and critical care patients in intensive care units; HRCT of the thorax is regarded as the mainstay of imaging evaluation of lung disorders, enabling characterization and quantification of pulmonary involvement. Aims of this review are to describe LU and chest HRCT main imaging features of COVID-19 pneumonia, and to provide state-of-the-art insights regarding the integrated role of these techniques in the clinical decision-making process of patients affected by this infectious disease.

13 September 2007 in Abdominal Radiology
Verified
Journal Article
Closed access
PDF file
RGRossano Girometti
Rossano Girometti
Lorenzo CereserLorenzo Cereser
Lorenzo Cereser
GCGiuseppe Como
Giuseppe Como
CZChiara Zuiani
Chiara Zuiani
MBMassimo Bazzocchi
Massimo Bazzocchi

1 September 2010 in Journal of Computer Assisted Tomography
Verified
Journal Article
Closed access
Lorenzo CereserLorenzo Cereser
Lorenzo Cereser
AFAlessandro Furlan
Alessandro Furlan
DBDaniele Bagatto
Daniele Bagatto
RGRossano Girometti
Rossano Girometti
GCGiuseppe Como
Giuseppe Como
MBMassimo Bazzocchi
Massimo Bazzocchi
To retrospectively compare portal venous phase (PVP) and delayed phase (DP) for the detection of tumor washout at gadobenate dimeglumine-enhanced liver magnetic resonance imaging (MRI) in cirrhotic patients with hypervascular hepatocellular carcinoma (HCC). Thirty-three patients with 55 HCCs underwent 1.5-T MRI by means of fat-suppressed T1-weighted sequence obtained before and after gadobenate dimeglumine administration, during early and late arterial phases, PVP (70 seconds), and DP (180 seconds). Detection rates of contrast washout of hypervascular HCCs and tumor-to-liver contrast on PVP and DP were measured and compared. Among 54 hypervascular HCCs, washout was present in 24 (44%) of 54 tumors on PVP and in 44 (82%) of 54 on DP (P < 0.001). In 20 (37%) of 54 tumors, washout was deemed present only on DP. Delayed phase images yielded significantly higher mean tumor-to-liver contrast absolute values compared with PVP images (-24.5 [56.1] vs -9.3 [52.6], P = 0.001). Delayed phase is superior to PVP for the washout detection of hypervascular HCC at gadobenate dimeglumine-enhanced MRI of cirrhotic liver.